Cibus, Inc., an agricultural biotechnology company, announced its intention to offer shares of Class A common stock in an underwritten public offering.
The company plans to grant underwriters a 45-day option to purchase up to 15% of the offered shares. Roth Capital Partners and A.G.P./Alliance Global Partners are acting as joint book-running managers for the offering.
Cibus intends to use the net proceeds to fund the development of new seed traits, improve existing ones, support Trait Machine operations, and for working capital and general corporate purposes.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.